- alle zwei WochenErscheinungsrhythmus
- 46 mintypische Länge
- vor 4 Tagenletzte Folge
Folgenzu den neuesten
Adam Marblestone - scientific moonshots
We talk with Adam Marblestone about his work with moonshot science and technology projects, exciting advances in nanotechnology and AI, and his PhD work using expansion microscopy to map neural connections. (Recorded on December 18, 2020) T
Tony Altar - CNS drug development and skateboarding
We speak with C. Anthony Altar, PhD, president and COO of Splice Therapeutics, about his successful career in neuropharmacology and his role in pioneering the sport of skateboarding in the 1960's. (Recorded on November 19, 2020) The Bioinfo
Quin Wills - recovering livers for transplant
We chat with Quin Wills, co-founder of Ochre Bio, about growing a biotech startup internationally, how genomics can increase the success of liver transplants, and his treehouse community in Costa Rica. (Recorded on November 10, 2020) The Bi
Jason Stein - psychiatric genomics
In our latest podcast, Grant talks with Jason Stein, assistant professor of genetics at UNC, about the latest omics techniques used to study schizophrenia, the role of academia and industry in drug discovery, and Jason's unusual path to bio
Ben Logsdon - omics in neurodegeneration
In this episode, Grant sits down with Ben Logsdon, director of computational biology at Cajal Neuroscience (https://cajalneuro.com/), to discuss new perspectives in Alzheimer's Disease research, incentives in academia, teamwork, and societa
Chris Ponting - ME genomics, COVID, CRISPR
In this episode, Grant sits down with Chris Ponting, chair of medical bioinformatics at the University of Edinburgh. They talk about myalgic encephalomyelitis (ME) and potential parallels to COVID-19 "long-haulers", CRISPR, and ecological d
Razib Khan - consumer genomics, academia, COVID
In the first episode of The Bioinformatics CRO Podcast, our founder and CEO Grant Belgard sits down with Razib Khan, geneticist, science communicator and director of science at the Insitome Institute, to discuss consumer genomics, SARS-CoV-
